Inspired by patients. Driven by data. Powered by science. These are just a few values that help describe who Silverback is, but our commitment and purpose go deeper.
Silverback was founded in 2016 in the heart of Seattle, Washington, where our multi-disciplinary team is developing effective and enduring treatments for patients.
We are singularly driven to create potent therapeutic molecules that are systemically administered to patients, but act only at the sites of disease – sparing healthy tissues from unwanted side effects.
We believe it’s finally possible to overcome some of the major barriers
We believe we can overcome major barriers in treating patients with cancer, chronic viral infections and other serious diseases. How?
Our proprietary ImmunoTAC technology – a platform designed to strategically pair payloads that modulate key disease-modifying pathways with monoclonal antibodies directed to specific disease sites.
The Silverback Team
Our team includes some of the industry’s most accomplished leaders, scientists, drug developers and clinicians. What makes us who we truly are is our shared passion for bringing victories to patients.